Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Public Access to Drugs Meets Health Needs, Cuts Costs

A study shows adding universal access to essential drugs as part of Canada’s health care system would meet much of that country’s pharmaceutical needs and save billions of dollars. . . . → Read More: Public Access to Drugs Meets Health Needs, Cuts Costs

Nuclear Cancer Therapy Company Launches, Raises $25M

A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario. . . . → Read More: Nuclear Cancer Therapy Company Launches, Raises $25M

Slot Machine Gamblers Get Hooked in Trance-Like State

Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result. . . . → Read More: Slot Machine Gamblers Get Hooked in Trance-Like State

Novo Nordisk to Open Oxford Diabetes Research Center

The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K. . . . → Read More: Novo Nordisk to Open Oxford Diabetes Research Center

Cell Biotech Gains Organoid Technology

A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs. . . . → Read More: Cell Biotech Gains Organoid Technology

Peptide-Infused Gel Shown to Heal Chronic Wounds

A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment. . . . → Read More: Peptide-Infused Gel Shown to Heal Chronic Wounds

Stem Cell Therapy Company Formed, Staked to $225M

A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. . . . → Read More: Stem Cell Therapy Company Formed, Staked to $225M

Commercial Genome Service Launches Based on Open Data

A start-up software company is offering genetic analysis services for research and precision medicine that comply with open standards and access Google’s genomic data sets. . . . → Read More: Commercial Genome Service Launches Based on Open Data

University Spin-Off Developing Sepsis Drug

A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections. . . . → Read More: University Spin-Off Developing Sepsis Drug

Robo-Bacteria Engineered for Cancer Drug Delivery

A biomedical engineering team designed a technology for precise deployment of drugs to tumors with bacteria modified to deliver their cargoes. . . . → Read More: Robo-Bacteria Engineered for Cancer Drug Delivery